Summary:
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of AGN-241751 in
Adult Participants with Major Depressive Disorder
Qualified Participants Must:
Male or female participants must be 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and travel